Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ShangPharma Reports 26% Increase in Q1 Revenues
Seeking Alpha
Sunday, May 22, 2011 - 4:32pm
tags:
ShangPharma, CROs
3 Low Beta Pharma Growth Stocks for Uncertain Times
Seeking Alpha
Sunday, May 22, 2011 - 4:31pm
tags:
Teva Pharmaceuticals, Questcor Pharmaceuticals, Emergent BioSolutions
The Next Big Thing In Biotech: ASCO Stocks (video)
The Street
Sunday, May 22, 2011 - 4:30pm
tags:
investors
Johnson & Johnson To Present Review of its Pharmaceutical Business
Galaxy Stocks
Saturday, May 21, 2011 - 11:53am
tags:
JNJ
Bruce Berkowitz Returns to Pharmaceuticals in Q1, Except Pfizer
Guru Focus
Saturday, May 21, 2011 - 11:50am
tags:
investors
Big Pharma's Golden Age Leads To Generics Windfall
NPR
Saturday, May 21, 2011 - 11:43am
tags:
generics
Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the first quarter ended March 31, 2011
Genetic Engineering News
Saturday, May 21, 2011 - 11:42am
tags:
Angiotech, earnings
One Reason the Street Should Love Novo Nordisk's Earnings
Motley Fool
Saturday, May 21, 2011 - 11:17am
tags:
Novo Nordisk, earnings
J&J’s McNeil Unit Is Ordered to Pay $10 Million to Girl Injured by Motrin
Bloomberg
Saturday, May 21, 2011 - 11:16am
tags:
JNJ, McNeil, lawsuits, Motrin
Mylan Remains Neutral
Yahoo/Zacks
Saturday, May 21, 2011 - 11:15am
tags:
Mylan
Pfizer's Axitinib Encourages
Yahoo/Zacks
Saturday, May 21, 2011 - 11:14am
tags:
Pfizer, Axitinib, renal cell carcinoma
Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Yahoo/BusinessWire
Saturday, May 21, 2011 - 11:11am
tags:
Sutent, neuroendocrine tumors, Pfizer
Novartis Adds New Drug Approvals In May
Investor's Business Daily
Saturday, May 21, 2011 - 11:10am
tags:
Novartis, Afinitor, neuroendocrine tumors
Abbott Hits a Triple
Motley Fool
Saturday, May 21, 2011 - 11:08am
tags:
Abbott Laboratories, TriLipix, cholesterol
J&J Puerto Rico Plant Has ‘Deeply Troubling’ Lack of Oversight
Bloomberg
Saturday, May 21, 2011 - 11:07am
tags:
JNJ
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Saturday, May 21, 2011 - 11:05am
tags:
Benlysta, Human Genome Sciences, Vibativ, Theravance, GSK, Victrelis, Merck, Xgeva, Amgen, Yervoy, Bristol-Myers Squibb, Fampyra, Acorda Therapeutics, Biogen Idec
Amgen Announces Voting Results Of Annual Meeting of Stockholders
Yahoo/PR NewsWire
Saturday, May 21, 2011 - 11:01am
tags:
Amgen
Targacept prices public offering for 3.7M shares
Yahoo/AP
Saturday, May 21, 2011 - 11:01am
tags:
Targacept, IPOs
Risk-Reward Balanced at Allos
Yahoo/Zacks
Saturday, May 21, 2011 - 11:00am
tags:
Allos
Codexis Becomes Target for Suitors Seeking Enzymes, Chief Executive Says
Bloomberg
Saturday, May 21, 2011 - 10:46am
tags:
Codexis, enzymes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.